Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Non-small Lung Cancer × taletrectinib × 1 year × Clear all

Status

Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 4 Thoracic Neoplasms 1 Respiratory Tract Neoplasms 1 Respiratory Tract Diseases 1 Non-small Lung Cancer 1 Neoplasms by Site 1 Neoplasms 1 Lung Neoplasms 1 Lung Diseases 1 Carcinoma, Bronchogenic 1 Carcinoma 1 Breast Neoplasms 1

Interventions

toripalimab 1 taletrectinib 1 Injections 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07199010 2025-09-30

Real-world Study of Taletrectinib in Advanced ROS1+ NSCLC Following Entrectinib Progression

Innovent Biologics (Suzhou) Co. Ltd.

Not yet recruiting

Non-small Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡